Skip Navigation


American Journal of Epidemiology Advance Access originally published online on April 3, 2007
American Journal of Epidemiology 2007 165(12):1397-1404; doi:10.1093/aje/kwm029
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Tables
Right arrow All Versions of this Article:
165/12/1397    most recent
kwm029v2
kwm029v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Engel, S. M.
Right arrow Articles by Wolff, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engel, S. M.
Right arrow Articles by Wolff, M. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Copyright © 2007 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.

ORIGINAL CONTRIBUTIONS

Prenatal Organophosphate Metabolite and Organochlorine Levels and Performance on the Brazelton Neonatal Behavioral Assessment Scale in a Multiethnic Pregnancy Cohort

Stephanie M. Engel1, Gertrud S. Berkowitz1, Dana B. Barr2, Susan L. Teitelbaum1, Jodi Siskind1, Stefanie J. Meisel1, James G. Wetmur3,4 and Mary S. Wolff1

1 Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY
2 National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA
3 Department of Microbiology, Mount Sinai School of Medicine, New York, NY
4 Department of Human Genetics, Mount Sinai School of Medicine, New York, NY

Correspondence to Dr. Stephanie M. Engel, Department of Community and Preventive Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1043, New York, NY 10029 (e-mail: Stephanie.Engel{at}mssm.edu).

Received for publication August 20, 2006. Accepted for publication December 21, 2006.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 References
 
Prenatal exposures to organophosphate pesticides and polychlorinated biphenyls have been associated with abnormal neonatal behavior and/or primitive reflexes. In 1998–2002, the Mount Sinai Children's Environmental Health Center (New York City) investigated the effects of indoor pesticide use and exposure to polychlorinated biphenyls on pregnancy outcome and child neurodevelopment in an inner-city multiethnic cohort. The Brazelton Neonatal Behavioral Assessment Scale was administered before hospital discharge (n = 311). Maternal urine samples were analyzed for six dialkylphosphate metabolites and malathion dicarboxylic acid. A random subset of maternal peripheral blood samples from the entire cohort (n = 194) was analyzed for polychlorinated biphenyls and 1,1'-dichloro-2,2'-bis(4-chlorophenyl)ethylene. Malathion dicarboxylic acid levels above the limit of detection were associated with a 2.24-fold increase in the number of abnormal reflexes (95% confidence interval: 1.55, 3.24). Likewise, higher levels of total diethylphosphates and total dialkylphosphates were associated with an increase in abnormal reflexes, as was total dimethylphosphates after paraoxonase expression was considered. No adverse associations were found with polychlorinated biphenyl or 1,1'-dichloro-2,2'-bis(4-chlorophenyl)ethylene levels and any behavior. The authors uncovered additional evidence that prenatal levels of organophosphate pesticide metabolites are associated with anomalies in primitive reflexes, which are a critical marker of neurologic integrity.

neonatal screening; pesticides; polychlorinated biphenyls; pregnancy; prenatal exposure delayed effects; reflex, abnormal


Abbreviations: BNBAS, Brazelton Neonatal Behavioral Assessment Scale; DDE, 1,1'-dichloro-2,2'-bis(4-chlorophenyl)ethylene; MDA, malathion dicarboxylic acid; PCB, polychlorinated biphenyl


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 References
 
Prenatal exposures to organophosphate pesticides and polychlorinated biphenyls (PCBs) have been associated with abnormalities in neonatal behavior and/or primitive reflexes as measured by the Brazelton Neonatal Behavioral Assessment Scale (BNBAS) (15). Exposure levels and the specific behavioral or motor abnormalities reported have varied, as have sample sizes and ethnicities represented. Nevertheless, certain patterns have emerged.

To our knowledge, only one study has examined prenatal exposure to organophosphate pesticides and neonatal behavior. An increase in the number of abnormal primitive reflexes was associated with prenatal dialkylphosphate levels in maternal urine in an agricultural community (5). The majority of previous studies evaluating the impact of prenatal PCB exposure have reported motor abnormalities, including abnormalities in primitive reflexes (13) and in overall motor performance (including motor maturity and tone) (3). Also frequently reported were abnormalities in autonomic stability, which relates to signs of infant stress related to homeostatic adjustments, such as tremor, startle, and changes in skin color and vascularization (1, 2, 4). We know of no previous report of the effect of 1,1'-dichloro-2,2'-bis(4-chlorophenyl)ethylene (DDE) exposure on neonatal behavior.

Although pesticide use in the urban environment of New York City is widespread (6, 7), the extent and nature of individual exposure may vary greatly. The Mount Sinai Children's Environmental Health Center investigated the impact of pesticide and PCB exposure on pregnancy outcome (810) and child neurodevelopment in an inner-city multiethnic cohort of women recruited during pregnancy.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 References
 
The Mount Sinai Children's Environmental Health Cohort study is a prospective multiethnic cohort that enrolled primiparous women who presented for prenatal care with singleton pregnancies at the Mount Sinai prenatal clinic and two private practices and who delivered their infants at Mount Sinai Hospital between May 1998 and July 2001 (8, 9). Mother-infant pairs were recruited during pregnancy. Of 1,450 eligible women who were approached, 33 percent consented to participate (n = 479) (9). Of these women, 75 were excluded because of medical complications (n = 3), infant or fetal demise (n = 2), very premature birth (delivery before 32 completed weeks or at less than 1,500 g) (n = 5), miscarriage (n = 1), delivery of an infant with genetic abnormalities or malformations (n = 5), inability to collect biologic specimens before birth (n = 12), change of hospital or residence outside New York City (n = 28), or loss to follow-up or refusal to continue to participate (n = 19), leaving 404 for whom birth data were available.

We administered a questionnaire to participants during their third trimester of pregnancy to obtain information on environmental exposures, sociodemographic characteristics, medical history, and lifestyle factors. Maternal blood was obtained during routine venipuncture at a mean gestational age of 31.2 (standard deviation, 3.7) weeks, and a urine sample was collected at the same time. Delivery characteristics and birth outcomes were obtained from a perinatal database within the Mount Sinai Department of Obstetrics, Gynecology and Reproductive Science. The BNBAS was administered before hospital discharge (n = 311) by one of four examiners. Examiners were either trained and certified by the Brazelton Institute or trained by a certified examiner. Examinations took place in a quiet, semidarkened, warm room adjacent to the neonatal nursery, or in the mother's private room. The BNBAS was not administered if the infant was admitted to the Neonatal Intensive Care Unit (n = 21); if the infant was delivered and discharged over a weekend (n = 43); if the parent refused (n = 5); if the infant was not testable (n = 2); or if study personnel were unavailable (n = 22). This study was approved by the Institutional Review Board of Mount Sinai School of Medicine.

Maternal urine samples were analyzed by the Centers for Disease Control and Prevention (Atlanta, Georgia) for six dialkylphosphate metabolites and malathion dicarboxylic acid (MDA). Laboratory and quality control methods (1113), and between-batch coefficients of variation (12, 14, 15), have been reported previously. Metabolite values within a group (diethyl or dimethyl) were correlated (16); therefore, we imputed for samples with one or more missing values by using the method described by Eskenazi et al. (16). We extended this method to also include imputation of metabolite values for women who were missing two metabolites in a class. In that instance, six regression models were run for subjects with a complete set of metabolites. In each model, one metabolite was predicted from another single metabolite. Then, each missing metabolite was imputed from these models. Diethyl- and dimethylphosphate metabolites were then summed on a molar basis (as nm/liter) to obtain total diethylphosphates and total dimethylphosphates, respectively, and together to obtain total dialkylphosphates levels. Samples of urine that contained less than 20 mg/dl of creatinine (n = 26) were excluded from organophosphate metabolite analyses. A random subset (n = 194) distributed equally by maternal race/ethnicity of maternal peripheral blood samples from the entire cohort was analyzed for PCBs and DDE. PCBs were defined as the sum of congeners 118, 153, 138, and 180 (13). Total lipids (g/liter) were calculated by using cholesterol and triglycerides (17) determined on 174 plasma samples with sufficient volume. Of the infants who were administered the BNBAS, 151 had PCB and DDE levels measured prenatally.

The BNBAS includes 28 behavioral items and 18 primitive reflexes. The seven-cluster scoring method developed by Lester et al. (18) is typically used to reduce the dimensionality of the data; it divides infant behavior into seven domains: 1) habituation (n = 183), ability to respond to and inhibit discrete stimuli while asleep; 2) orientation (n = 282), attention to visual and auditory stimuli and quality of overall alertness; 3) motor (n = 311), motor performance and quality of movement and tone; 4) range of state (n = 310), a measure of infant arousal and state lability; 5) regulation of state (n = 309), ability to regulate state in the face of increasing levels of stimulation; 6) autonomic stability (n = 310), signs of stress related to homeostatic adjustments of the central nervous system; and 7) number and type of abnormal primitive reflexes (n = 311). Details of the Lester scoring method have been described previously (5, 18, 19).

Data were analyzed by using SAS software, version 9.1 (SAS Institute, Inc., Cary, North Carolina). Generalized linear models were used to analyze associations between biomarker levels and each domain except abnormal reflexes. Poisson regression was used to analyze the relation between biomarker levels and the number of abnormal reflexes because of the count nature of the data. The distribution of abnormal reflexes was skewed to the right, with a large number of zero values. When necessary, we corrected for overdispersion as indicated in the tables. Overdispersion may cause underestimation of the standard errors of regression estimates. We adjusted for overdispersion by introducing a scale parameter estimated by the deviance divided by degrees of freedom.

Backward elimination was used to arrive at the final adjusted models. Covariates were eliminated if their exclusion caused less than a 20 percent change in the beta coefficient of the full model. The following were considered as potential confounders or effect modifiers: maternal age (continuous), race (White or non-White), marital status (single, married, living with the infant's father), education (<high school, high school, some college, ≥college degree), cesarean delivery (yes/no), delivery anesthesia (yes/no), infant age at examination (continuous), infant gender (male/female), infant jaundice (yes/no), and smoking (yes/no), alcohol consumption (yes/no), caffeine consumption (yes/no), or illicit drug use (yes/no) during pregnancy. Similar results were obtained when race was specified as a three-level class variable. Gestational age at delivery and birth weight were not evaluated for confounding because they are potentially causal intermediates. All models were adjusted for examiner. All biomarkers except MDA were included as log10 linear terms in the initial model selection stage. MDA was dichotomized at the limit of detection because only 21.6 percent of the population had detectable values. PCB models were additionally adjusted for laboratory batch. PCB and DDE models were run both with and without adjustment for serum lipids. Dialkylphosphate models were additionally adjusted for paraoxonase 1 enzyme level tertiles (20) and were run both with and without adjustment for urine creatinine. We also analyzed the possible interaction among paraoxonase 1, dialkylphosphate metabolite level, and abnormal reflexes. Paraoxonase 1 activity was determined as previously reported in plasma (µmol/minute per ml) by using phenylacetate as substrate (20).

A finding of two or more abnormal reflexes in a neonate often warrants further clinical investigation and possible intervention (19). Therefore, we conducted exploratory analyses of the association between multiple abnormal reflexes and prenatal pesticide levels, dichotomizing the number of abnormal reflexes at two or more in multivariable logistic regression models.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 References
 
Participants in this study were predominantly young, Black and Latina women with low educational attainment (table 1). The majority were unmarried at enrollment. Severely preterm births were excluded by design; therefore, most women delivered term infants (92.9 percent) of normal birth weight (97.8 percent). All BNBAS examinations were completed within 5 days of delivery, the majority (86.1 percent) within 2 days of delivery.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Characteristics of the population in a multiethnic pregnancy cohort (n = 311), Mount Sinai Hospital, New York City, 1998–2002

 
Environmental exposure distributions are shown in table 2. Regarding prenatal urinary organophosphate metabolites, there were strong and consistent associations between increased exposure and abnormal primitive reflexes (table 3). MDA levels above the limit of detection were associated with a 2.24-fold increase in the number of abnormal reflexes (95 percent confidence interval: 1.55, 3.24) in a Poisson regression model adjusted for examiner, anesthesia, paraoxonase 1 enzyme level, and creatinine. Likewise, relative to the first quartile, quartiles 2–4 of total diethylphosphates, total dimethylphosphates, and total dialkylphosphates were associated with an increased proportion of abnormal reflexes, although the associations did not increase monotonically and varied in their strength and precision (Web table 1) (This information is described in the first of four supplementary tables; each is referred to as "Web table" in the text and is posted on the Journal's website (http://aje.oupjournals.org/).), suggesting a possible threshold effect. After we adjusted for examiner and age at examination, we found that subjects with prenatal MDA levels above the limit of detection delivered infants who were 3.6 times more likely to have at least two abnormal reflexes (95 percent confidence interval: 1.5, 8.8). Likewise, subjects with prenatal total diethylphosphates levels above the median delivered infants who were 2.3 times more likely to have at least two abnormal reflexes (95 percent confidence interval: 1.1, 5.0). There was a strong interaction between paraoxonase 1 expression levels and total dimethylphosphates on risk of abnormal reflexes, such that infants born to women in the first (interaction p = 0.002) and second (interaction p = 0.01) tertiles (slower metabolizers) had a greater risk of abnormal reflexes than infants of those in the highest tertile (fast metabolizers). For women in the highest tertile of paraoxonase 1 expression, no increased risk of abnormal reflexes with increasing exposure was found. There was no interaction between total diethylphosphates and paraoxonase 1 (table 4).


View this table:
[in this window]
[in a new window]

 
TABLE 2. Organophosphate and organochlorine prenatal biomarker levels in a multiethnic pregnancy cohort, Mount Sinai Hospital, New York City, 1998–2002

 

View this table:
[in this window]
[in a new window]

 
TABLE 3. Relation between third-trimester urinary organophosphate metabolite biomarkers (nm/liter) and neonatal behavior in a multiethnic pregnancy cohort, Mount Sinai Hospital, New York City, 1998–2002

 

View this table:
[in this window]
[in a new window]

 
TABLE 4. Interactions among paraoxonase expression level, dialkylphosphate metabolites (nm/liter), and risk of abnormal reflexes in a multiethnic pregnancy cohort, Mount Sinai Hospital, New York City, 1998–2002

 
We evaluated the possibility that infant age may modify these associations by using a log10 linear term for total diethylphosphates, total dimethylphosphates, and total dialkylphosphates, a dichotomized term for MDA (at the limit of detection), and a dichotomized term for age at BNBAS administration (1 day vs. ≥2 days of age). With the exception of MDA, there appeared to be stronger associations between metabolite levels and abnormal reflexes for examinations performed after the first day of life, although only the total dimethylphosphates interaction p value was ≤0.10. In contrast, an interaction (p = 0.10) with MDA showed the reverse; that is, for infants examined before day 2, the relation between MDA and abnormal reflexes was stronger (relative risk = 2.51, 95 percent confidence interval: 1.61, 3.90) compared with that for infants examined later (relative risk = 1.34, 95 percent confidence interval: 0.72, 2.49) (Web table 2).

Of the 308 infants for whom we were able to evaluate all 18 primitive reflexes, 198 (64 percent) had all reflexes within the normal range, 55 (18 percent) had one abnormal reflex, 25 (8 percent) had two abnormal reflexes, and 30 (10 percent) had three or more abnormal reflexes. The majority of abnormal reflexes were due to hypotonicity (which includes a reflex not elicited after stimulation), although a small number of hypertonic (n = 5) and asymmetric (n = 6) reflexes were observed. In exploratory analyses, we examined whether specific abnormal reflexes might be related to elevated organophosphate pesticide metabolite levels. In chi-square analyses, MDA levels above the limit of detection were associated with both abnormal "crawling" and "resist arms" reflexes (p < 0.01). Likewise, a higher total diethylphosphates level was associated with an abnormal "crawling" reflex when the Wilcoxon signed-rank test was used (p < 0.05).

Prenatal PCB level was associated with range of state, but in an unexpected direction. Increasing PCB level was positively associated with an improved range of state, in a dose-dependent manner (table 5 and Web table 3). A similar trend, but less strong, was seen for regulation of state. There were no notable associations between prenatal DDE levels and infant behavior or reflexes (table 5 and Web table 3).


View this table:
[in this window]
[in a new window]

 
TABLE 5. Relation between third-trimester serum organochlorine biomarkers (µg/liter) and neonatal behavior in a multiethnic pregnancy cohort, Mount Sinai Hospital, New York City, 1998–2002

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 References
 
A high prevalence of pesticide use in two New York City pregnancy cohorts has been reported (8, 21). All of the women who participated in personal air monitoring of their home had detectable levels of diazinon, chlorpyrifos, carbamate propoxur, and o-phenylphenol (21). In our cohort, 46 percent reported that pesticides had been applied in their home during their pregnancy (8). Prenatal exposure to organophosphate pesticides was associated with reduced infant head circumference after considering paraoxonase 1 in our cohort (9) and reduced infant birth weight and length (22) in another inner-city minority cohort. Additionally, organophosphate pesticide metabolites were associated with decreased length of gestation in a rural, agricultural population (16).

We found an association between both generic and pesticide-specific biomarkers of prenatal organophosphate pesticides and an increased number of abnormal primitive reflexes in neonates, consistent with a previously reported association in a more highly exposed cohort (5). Although there did not appear to be a substantially increased risk of abnormal reflexes due to dimethylphosphates overall, once we accounted for paraoxonase 1 expression level, women in lower tertiles of paraoxonase 1 expression (i.e., slow organophosphate pesticide metabolizers) had a significantly increased risk of abnormal reflexes. In addition, subjects with detectable MDA, or greater than the median total diethylphosphates levels, had an elevated risk of delivering infants with two or more abnormal reflexes, a clinically significant threshold (19). Our findings are remarkably consistent with those of Young et al. (5); for each log10 unit increase in total dialkylphosphates, these authors reported a 26 percent increased risk of abnormal reflexes, and we found a 32 percent increased risk. The magnitudes of association were also similar for total diethylphosphates (relative riskYoung = 1.25, relative riskEngel (current study) = 1.49) and total dimethylphosphates (relative riskYoung = 1.20, relative riskEngel (current study) = 1.13). Both studies found stronger associations between dialkylphosphate metabolites and abnormal reflexes for older children, although, in our study, the statistical interaction with day of administration was not significant.

The relation between MDA, a malathion-specific metabolite, and abnormal reflexes in our cohort appeared to be age dependent, such that the most pronounced effect was observed in infants evaluated within the first day of life. This finding conflicts with the suggestion of later effects for dialkylphosphate metabolites, including dimethylphosphates, which encompasses nonspecific metabolites of malathion. Because the class of dimethylphosphates includes breakdown products of numerous organophosphate pesticides, it is unclear what pesticides may be driving this disparity.

It is possible that postentry exclusions in our cohort may have biased our findings if they were associated with both organophosphate pesticide levels and neonatal behavior. Most of our excluded women were those who moved out of the study area, were lost-to-follow up, or lacked prenatal biologic specimens, which largely reflect socioeconomic condition. We recently described that, compared with Blacks or Hispanics, Whites had slightly higher levels of dimethylphosphates and that a larger proportion of older women, relative to younger women, had MDA levels above the limit of detection (10). However, in our analysis, maternal age and race were not associated with number of abnormal reflexes. Additionally, the consistency of our findings with those of Young et al. (5) suggests that bias is unlikely to account for the entire effect. The BNBAS was not administered to a substantial fraction (23 percent) of the initial cohort for various reasons, including weekend infant delivery. Thus, any factors related to weekend delivery (e.g., fewer inductions) would be underrepresented among our tested subjects. However, this possibility alone does not impose a bias on our findings, even if those factors are related to exposure or disease status. That is, fewer induced deliveries with pesticide exposure, for example, would affect precision, but that alone would not affect the validity of the estimates. Only under the scenario in which a different exposure-disease relation existed between those tested and not tested would bias result.

The Mount Sinai Children's Environmental Health Center enrolled subjects between 1998 and 2002, which overlaps with the period when chlorpyrifos and diazinon were being phased out of residential use (23, 24). However, in 1997, chlorpyrifos was the most heavily used insecticide by pest control operators at the New York City Housing Authority (7). Chlorpyrifos, which is metabolized to diethylphosphates, is a known neurotoxicant (7). Systemic toxicity of organophosphates is achieved through the inhibition of cholinesterases. Accumulating evidence suggests that developmental toxicity may result from a disruption in the maturation of neuronal cells and the organization of synaptic networks (25). A comparative analysis of developmental and systemic toxicity related to chlorpyrifos and diazinon found them to be similar, although diazinon, which is also metabolized to diethylphosphates, appeared slightly less potent by some measures (25).

Behavioral sequelae of prenatal organophosphate pesticide exposure have been reported in animal studies. Pups prenatally exposed to low levels of chlorpyrifos during pregnancy exhibited a significant alteration in cliff avoidance and the righting reflex at postnatal days 1 and 3 (26). Some chlorpyrifos-associated behavioral anomalies have been linked to disruption of the serotonin systems in the perinatal period, leading to global upregulation of serotonin-related synaptic proteins (27). Additionally, some chlorpyrifos-associated behavioral anomalies appear to persist into adulthood (28). However, this study reflects only pesticide metabolites, and it is unclear how their levels relate to the parent organophosphate.

PCBs are among the most widely studied neurotoxicants. In previous studies that have used the BNBAS to evaluate their in utero effects on infant behavior, altered motor performance and reflexes (13), habituation (2, 4), range of state (1), and autonomic stability (1, 2, 4) have been reported. The differences in these findings are likely due to variability in PCB level and congener mixture and to the populations under study. In our population, PCB levels were quite low overall and were related to both country of origin and fish consumption (13). We report an unexpected association between increasing PCB levels and improved range of state that was dose dependent and monotonic. A similar trend was seen for regulation of state. A recent small study linked decosahexaenoic acid levels in breast milk to improved range of state in infants at 9 days of age (29). Decosahexaenoic acid is an omega-3-fatty acid present in fish, particularly cold-water fish. It is possible, therefore, that our results suggesting a positive effect for PCB exposure are actually attributable to their correlation with fish consumption and therefore omega-3-fatty acid levels during pregnancy.

Observing two or more abnormal reflexes in a neonate is considered clinically significant and often results in a more intensive neurologic examination and possible intervention (19). In our cohort, very few maternal, peripartum, or neonatal characteristics predicted abnormal reflexes except infant age, gestational age at delivery, and anesthesia use during delivery (Web table 4). However, the prognostic utility of a single measurement of infant behavior shortly after delivery is unclear. Likewise, organophosphate pesticide metabolites have short half-lives, and our exposure measurements rely on a single urine specimen taken during the third trimester. However, if sources and patterns of exposure (e.g., residential pesticide use or exposure from a food source) are unchanged, we can assume that a single measurement reflects a typical measurement at any time during pregnancy. Even so, misclassification of both exposure and outcome is probable in this study, although they are likely to be independent of one another. Additional research is under way to assess their impact on subsequent markers of neurodevelopment, and therefore the persistence of these associations over time.


    ACKNOWLEDGMENTS
 
This research was supported by NIEHS/EPA Children's Center grants ES09584 and R827039, The New York Community Trust, and ATSDR/CDC/ATPM.

Conflict of interest: none declared.


    References
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 References
 

  1. Jacobson JL, Jacobson SW, Fein GG, et al. Prenatal exposure to an environmental toxin: a test of the multiple effects model. Dev Psychol (1984) 20:523–32.[CrossRef][Web of Science]
  2. Lonky E, Reihman J, Darvill T, et al. Neonatal behavioral assessment scale performance in humans influenced by maternal consumption of environmentally contaminated Lake Ontario fish. J Great Lakes Res (1996) 22:198–212.
  3. Rogan WJ, Gladen BC, McKinney JD, et al. Neonatal effects of transplacental exposure to PCBs and DDE. J Pediatr (1986) 109:335–41.[Web of Science][Medline]
  4. Stewart P, Reihman J, Lonky E, et al. Prenatal PCB exposure and neonatal behavioral assessment scale (NBAS) performance. Neurotoxicol Teratol (2000) 22:21–9.[CrossRef][Web of Science][Medline]
  5. Young JG, Eskenazi B, Gladstone EA, et al. Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. Neurotoxicology (2005) 26:199–209.[CrossRef][Web of Science][Medline]
  6. Kass DE, Thier AL, Leighton J, et al. Developing a comprehensive pesticide health effects tracking system for an urban setting: New York City's approach. Environ Health Perspect (2004) 112:1419–23.[Web of Science][Medline]
  7. Landrigan PJ, Claudio L, Markowitz SB, et al. Pesticides and inner-city children: exposures, risks, and prevention. Environ Health Perspect (1999) 107(suppl 3):431–7.[Web of Science][Medline]
  8. Berkowitz GS, Obel J, Deych E, et al. Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environ Health Perspect (2003) 111:79–84.[Web of Science][Medline]
  9. Berkowitz GS, Wetmur JG, Birman-Deych E, et al. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect (2004) 112:388–91.[Web of Science][Medline]
  10. Wolff MS, Engel SM, Berkowitz GS, et al. Prenatal pesticide and PCB exposure and birth outcomes. Pediatr Res (2007) 61:243–50.[Web of Science][Medline]
  11. Barr DB, Allen R, Olsson AO, et al. Concentrations of selective metabolites of organophosphorus pesticides in the United States population. Environ Res (2005) 99:314–26.[Medline]
  12. Bravo R, Caltabiano LM, Weerasekera G, et al. Measurement of dialkyl phosphate metabolites of organophosphorus pesticides in human urine using lyophilization with gas chromatography-tandem mass spectrometry and isotope dilution quantification. J Expo Anal Environ Epidemiol (2004) 14:249–59.[CrossRef][Web of Science][Medline]
  13. Wolff MS, Deych E, Ojo F, et al. Predictors of organochlorines in New York City pregnant women, 1998 –2001. Environ Res (2005) 97:170–7.[Medline]
  14. Gammon MD, Wolff MS, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev (2002) 11:686–97.[Abstract/Free Full Text]
  15. Olsson AO, Baker SE, Nguyen JV, et al. A liquid chromatography–tandem mass spectrometry multiresidue method for quantification of specific metabolites of organophosphorus pesticides, synthetic pyrethroids, selected herbicides, and deet in human urine. Anal Chem (2004) 76:2453–61.[Medline]
  16. Eskenazi B, Harley K, Bradman A, et al. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect (2004) 112:1116–24.[Web of Science][Medline]
  17. Phillips DL, Pirkle JL, Burse VW, et al. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol (1989) 18:495–500.[CrossRef][Web of Science][Medline]
  18. Lester BM, Als H, Brazelton TB. Regional obstetric anesthesia and newborn behavior: a reanalysis toward synergistic effects. Child Dev (1982) 53:687–92.[CrossRef][Web of Science][Medline]
  19. Brazelton TB, Nugent JK. Neonatal behavioral assessment scale. (1995) London, United Kingdom: Mac Keith Press.
  20. Chen J, Chan W, Wallenstein S, et al. Haplotype-phenotype relationships of paraoxonase-1. Cancer Epidemiol Biomarkers Prev (2005) 14:731–4.[Abstract/Free Full Text]
  21. Whyatt RM, Camann DE, Kinney PL, et al. Residential pesticide use during pregnancy among a cohort of urban minority women. Environ Health Perspect (2002) 110:507–14.[Web of Science][Medline]
  22. Whyatt RM, Camann D, Perera FP, et al. Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol Appl Pharmacol (2005) 206:246–54.[CrossRef][Web of Science][Medline]
  23. US EPA. Chlorpyrifos. Revised risk assessment and agreement with registrants. (2000) Washington, DC: US Environmental Protection Agency, Office of Pesticide Programs. (http://www.epa.gov/pesticides/op/chlorpyrifos/agreement.pdf).
  24. US EPA. Diazinon. Revised risk assessment and agreement with registrants. (2001) Washington, DC: US Environmental Protection Agency, Office of Pesticide Programs. (http://www.epa.gov/pesticides/op/diazinon/agreement.pdf).
  25. Slotkin TA, Levin ED, Seidler FJ. Comparative developmental neurotoxicity of organophosphate insecticides: effects on brain development are separable from systemic toxicity. Environ Health Perspect (2006) 114:746–51.[Web of Science][Medline]
  26. Chanda SM, Pope CN. Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing rats. Pharmacol Biochem Behav (1996) 53:771–6.[CrossRef][Web of Science][Medline]
  27. Aldridge JE, Meyer A, Seidler FJ, et al. Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ Health Perspect (2005) 113:1027–31.[Web of Science][Medline]
  28. Levin ED, Addy N, Baruah A, et al. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol Teratol (2002) 24:733–41.[CrossRef][Web of Science][Medline]
  29. Hart SL, Boylan LM, Carroll SR, et al. Brief report: newborn behavior differs with decosahexaenoic acid levels in breast milk. J Pediatr Psychol (2006) 31:221–6.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Tables
Right arrow All Versions of this Article:
165/12/1397    most recent
kwm029v2
kwm029v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Engel, S. M.
Right arrow Articles by Wolff, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engel, S. M.
Right arrow Articles by Wolff, M. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?